Dissecting the mechanism of CRISPR–Cas technologies to design efficient biotechnologies
Nature Structural & Molecular Biology · 2024
DOI: 10.1038/s41594-024-01366-8 ↗Kurz gefasst
Leserbrief in der Zeitschrift Nature Structural & Molecular Biology, 2024. Verfasst von Jasleen Gill. Beteiligte Einrichtung: Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jasgill@upenn.edu. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Biotechnology. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 8 Literaturangaben. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jasgill@upenn.edu.
ORCID-Profile: Jasleen Gill
Förderung
- NIGMS NIH HHS
Zitieren
APA
Gill, J. (2024). Dissecting the mechanism of CRISPR–Cas technologies to design efficient biotechnologies. Nature Structural & Molecular Biology. https://doi.org/10.1038/s41594-024-01366-8
Vancouver
Gill J. Dissecting the mechanism of CRISPR–Cas technologies to design efficient biotechnologies. Nature Structural & Molecular Biology. 2024. doi:10.1038/s41594-024-01366-8
BibTeX
@article{Gill2024,
author = {Gill, Jasleen},
title = {Dissecting the mechanism of CRISPR–Cas technologies to design efficient biotechnologies},
journal = {Nature Structural & Molecular Biology},
year = {2024},
doi = {10.1038/s41594-024-01366-8}
}
EUVIMED